3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
1
Myasthenia Gravis
1
Interventions
Pyridostigmine Bromide
4
Tacrolimus
2
Prednisone
2
Mycophenolic Acid
2
tocilizumab
1
sargramostim
1
Thymectomy
1
Tablets
1
Steroids
1
Sternotomy
1
Rituximab
1
Methylprednisolone
1
Methotrexate
1
Immunosuppressive Agents
1
Immunoglobulins, Intravenous
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Exercise
1
Data Collection
1
Cyclosporine
1
Cyclophosphamide
1
Azathioprine
1
Amifampridine
1
Alkalies
1
Albuterol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Myasthenia Gravis
×
Alkalies
×
Clear all
NCT05919407
2023-06-26
IMPACT-MG
Leiden University Medical Center
Phase 3
Unknown
24 enrolled